PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy.
Prif Awduron: | Cooper, C, Liggins, A, Ait-Tahar, K, Roncador, G, Banham, A, Pulford, K |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2006
|
Eitemau Tebyg
-
Cytotoxic T-Cell Response to the Cancer Testis Antigen PASD1 In Multiple Myeloma: PASD1 Peptides for a Generic Vaccine to Treat PASD1-Positive Haematological Malignancies.
gan: Campbell, A, et al.
Cyhoeddwyd: (2010) -
Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
gan: Ait-Tahar, K, et al.
Cyhoeddwyd: (2009) -
PASD1 is a potential multiple myeloma-associated antigen.
gan: Sahota, S, et al.
Cyhoeddwyd: (2006) -
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
gan: Joseph-Pietras, D, et al.
Cyhoeddwyd: (2010) -
Cytotoxic T-cell response to the PASD1 protein in patients with diffuse large B-cell lymphoma
gan: Ait-Tahar, K, et al.
Cyhoeddwyd: (2009)